nach oben

Diabetologia

Erschienen in:

01.03.2014 | Article

Matrix metalloproteinase 9 opposes diet-induced muscle insulin resistance in mice

verfasst von: Li Kang, Wesley H. Mayes, Freyja D. James, Deanna P. Bracy, David H. Wasserman

Erschienen in: Diabetologia | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Increased extracellular matrix (ECM) collagen is a characteristic of muscle insulin resistance. Matrix metalloproteinase (MMP) 9 is a primary enzyme that degrades collagen IV (ColIV). As a component of the basement membrane, ColIV plays a key role in ECM remodelling. We tested the hypotheses that genetic deletion of MMP9 in mice increases muscle ColIV, induces insulin resistance in lean mice and worsens diet-induced muscle insulin resistance.

Methods

Wild-type (Mmp9 ^+/+) and Mmp9-null (Mmp9 ^−/−) mice were chow or high-fat (HF) fed for 16 weeks. Insulin action was measured by the hyperinsulinaemic–euglycaemic clamp in conscious weight-matched surgically catheterised mice.

Results

Mmp9 ^−/− and HF feeding independently increased muscle ColIV. ColIV in HF-fed Mmp9 ^−/− mice was further increased. Mmp9 ^−/− did not affect fasting insulin or glucose in chow- or HF-fed mice. The glucose infusion rate (GIR), endogenous glucose appearance (EndoRa) and glucose disappearance (Rd) rates, and a muscle glucose metabolic index (Rg), were the same in chow-fed Mmp9 ^+/+ and Mmp9 ^−/− mice. In contrast, HF-fed Mmp9 ^−/− mice had decreased GIR, insulin-stimulated increase in Rd and muscle Rg. Insulin-stimulated suppression of EndoRa, however, remained the same in HF-fed Mmp9 ^−/− and Mmp9 ^+/+ mice. Decreased muscle Rg in HF-fed Mmp9 ^−/− was associated with decreased muscle capillaries.

Conclusions/interpretation

Despite increased muscle ColIV, genetic deletion of MMP9 does not induce insulin resistance in lean mice. In contrast, this deletion results in a more profound state of insulin resistance, specifically in the skeletal muscle of HF-fed mice. These results highlight the importance of ECM remodelling in determining muscle insulin resistance in the presence of HF diet.

Nur mit Berechtigung zugänglich

Richardson DK, Kashyap S, Bajaj M et al (2005) Lipid infusion decreases the expression of nuclear encoded mitochondrial genes and increases the expression of extracellular matrix genes in human skeletal muscle. J Biol Chem 280:10290–10297PubMedCrossRef

Berria R, Wang L, Richardson DK et al (2006) Increased collagen content in insulin-resistant skeletal muscle. Am J Physiol Endocrinol Metab 290:E560–E565PubMedCrossRef

Kang L, Ayala JE, Lee-Young RS et al (2011) Diet-induced muscle insulin resistance is associated with extracellular matrix remodeling and interaction with integrin alpha2beta1 in mice. Diabetes 60:416–426PubMedCrossRef

Kang L, Lantier L, Kennedy A et al (2013) Hyaluronan accumulates with high fat feeding and contributes to insulin resistance. Diabetes 62:1888–1896PubMedCrossRef

Thrailkill KM, Clay Bunn R, Fowlkes JL (2009) Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy. Endocrine 35:1–10PubMedCentralPubMedCrossRef

Brinckerhoff CE, Matrisian LM (2002) Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 3:207–214PubMedCrossRef

Weber BH, Vogt G, Pruett RC, Stohr H, Felbor U (1994) Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby’s fundus dystrophy. Nat Genet 8:352–356PubMedCrossRef

Martignetti JA, Aqeel AA, Sewairi WA et al (2001) Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nat Genet 28:261–265PubMedCrossRef

Peng WJ, Yan JW, Wan YN et al (2012) Matrix Metalloproteinases: a review of their structure and role in systemic sclerosis. J Clin Immunol 32:1409–1414PubMedCrossRef

10.

Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM (2000) Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 18:1135–1149PubMed

11.

Derosa G, Ferrari I, D’Angelo A et al (2008) Matrix metalloproteinase-2 and -9 levels in obese patients. Endothelium J Endothelial Cell Res 15:219–224CrossRef

12.

Signorelli SS, Malaponte G, Libra M et al (2005) Plasma levels and zymographic activities of matrix metalloproteinases 2 and 9 in type II diabetics with peripheral arterial disease. Vasc Med 10:1–6PubMedCrossRef

13.

Tinahones FJ, Coin-Araguez L, Mayas MD et al (2012) Obesity-associated insulin resistance is correlated to adipose tissue vascular endothelial growth factors and metalloproteinase levels. BMC Physiol 12:4PubMedCentralPubMedCrossRef

14.

Vu TH, Shipley JM, Bergers G et al (1998) MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93:411–422PubMedCentralPubMedCrossRef

15.

Acuff HB, Carter KJ, Fingleton B, Gorden DL, Matrisian LM (2006) Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment. Cancer Res 66:259–266PubMedCentralPubMedCrossRef

16.

Ducharme A, Frantz S, Aikawa M et al (2000) Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 106:55–62PubMedCentralPubMedCrossRef

17.

Asahi M, Asahi K, Jung JC, del Zoppo GJ, Fini ME, Lo EH (2000) Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab 20:1681–1689PubMedCrossRef

18.

Vermaelen KY, Cataldo D, Tournoy K et al (2003) Matrix metalloproteinase-9-mediated dendritic cell recruitment into the airways is a critical step in a mouse model of asthma. J Immunol 171:1016–1022PubMed

19.

Collins S, Martin TL, Surwit RS, Robidoux J (2004) Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiol Behav 81:243–248PubMedCrossRef

20.

Ayala JE, Bracy DP, McGuinness OP, Wasserman DH (2006) Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse. Diabetes 55:390–397PubMedCrossRef

21.

James DE, Burleigh KM, Kraegen EW (1986) In vivo glucose metabolism in individual tissues of the rat. Interaction between epinephrine and insulin. J Biol Chem 261:6366–6374PubMed

22.

Ayala JE, Bracy DP, Julien BM, Rottman JN, Fueger PT, Wasserman DH (2007) Chronic treatment with sildenafil improves energy balance and insulin action in high fat-fed conscious mice. Diabetes 56:1025–1033PubMedCrossRef

23.

Steele R, Wall JS, de Bodo RC, Altszuler N (1956) Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187:15–24PubMed

24.

Kraegen EW, James DE, Jenkins AB, Chisholm DJ (1985) Dose-response curves for in vivo insulin sensitivity in individual tissues in rats. Am J Physiol 248:E353–E362PubMed

25.

Bonner JS, Lantier L, Hasenour CM, James FD, Bracy DP, Wasserman DH (2013) Muscle-specific vascular endothelial growth factor deletion induces muscle capillary rarefaction creating muscle insulin resistance. Diabetes 62:572–580PubMedCrossRef

26.

Olfert IM, Howlett RA, Tang K et al (2009) Muscle-specific VEGF deficiency greatly reduces exercise endurance in mice. J Physiol 587:1755–1767PubMedCrossRef

27.

Tschop MH, Speakman JR, Arch JR et al (2012) A guide to analysis of mouse energy metabolism. Nat Methods 9:57–63CrossRef

28.

Kaiyala KJ, Morton GJ, Leroux BG, Ogimoto K, Wisse B, Schwartz MW (2010) Identification of body fat mass as a major determinant of metabolic rate in mice. Diabetes 59:1657–1666PubMedCrossRef

29.

Kaiyala KJ, Schwartz MW (2011) Toward a more complete (and less controversial) understanding of energy expenditure and its role in obesity pathogenesis. Diabetes 60:17–23PubMedCrossRef

30.

Hollborn M, Stathopoulos C, Steffen A, Wiedemann P, Kohen L, Bringmann A (2007) Positive feedback regulation between MMP-9 and VEGF in human RPE cells. Investig Ophthalmol Vis Sci 48:4360–4367CrossRef

31.

Bergers G, Brekken R, McMahon G et al (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2:737–744PubMedCentralPubMedCrossRef

32.

Pompei LM, Steiner ML, Theodoro TR et al (2013) Effect of estrogen therapy on vascular perlecan and metalloproteinases 2 and 9 in castrated rats. Climacteric J Int Menopause Soc 16:147–153CrossRef

33.

Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN (1988) Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37:1163–1167PubMedCrossRef

34.

Lee YS, Li P, Huh JY et al (2011) Inflammation is necessary for long-term but not short-term high-fat diet-induced insulin resistance. Diabetes 60:2474–2483PubMedCrossRef

35.

Sprague AH, Khalil RA (2009) Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 78:539–552PubMedCentralPubMedCrossRef

36.

Amento EP, Ehsani N, Palmer H, Libby P (1991) Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb 11:1223–1230PubMedCrossRef

37.

Galis ZS, Muszynski M, Sukhova GK et al (1994) Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 75:181–189PubMedCrossRef

38.

Tooke JE, Goh KL (1998) Endotheliopathy precedes type 2 diabetes. Diabetes Care 21:2047–2049PubMedCrossRef

39.

Tooke J (1999) The association between insulin resistance and endotheliopathy. Diabetes Obes Metab 1(Suppl 1):S17–S22

40.

Pinkney JH, Stehouwer CD, Coppack SW, Yudkin JS (1997) Endothelial dysfunction: cause of the insulin resistance syndrome. Diabetes 46(Suppl 2):S9–S13

41.

Kubota T, Kubota N, Kumagai H et al (2011) Impaired insulin signaling in endothelial cells reduces insulin-induced glucose uptake by skeletal muscle. Cell Metab 13:294–307PubMedCrossRef

42.

Braet F, Wisse E (2012) AFM imaging of fenestrated liver sinusoidal endothelial cells. Micron 43:1252–1258PubMedCrossRef

43.

Cogger VC, McNerney GP, Nyunt T et al (2010) Three-dimensional structured illumination microscopy of liver sinusoidal endothelial cell fenestrations. J Struct Biol 171:382–388PubMedCentralPubMedCrossRef

44.

Konstantinopoulos PA, Karamouzis MV, Papatsoris AG, Papavassiliou AG (2008) Matrix metalloproteinase inhibitors as anticancer agents. Int J Biochem Cell Biol 40:1156–1168PubMedCrossRef

45.

Hu J, van den Steen PE, Sang QX, Opdenakker G (2007) Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nat Rev Drug Discov 6:480–498PubMedCrossRef

Titel: Matrix metalloproteinase 9 opposes diet-induced muscle insulin resistance in mice
verfasst von: Li Kang
Wesley H. Mayes
Freyja D. James
Deanna P. Bracy
David H. Wasserman
Publikationsdatum: 01.03.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: Diabetologia / Ausgabe 3/2014
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-013-3128-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2014

The revolving door of ‘residual beta cell function’: cause or effect in medical reports?

Infection-related mortality is higher for kidney allograft recipients with pretransplant diabetes mellitus

Detection of enterovirus in the islet cells of patients with type 1 diabetes: what do we learn from immunohistochemistry?

A sustained increase in plasma NEFA upregulates the Toll-like receptor network in human muscle

Role for sterol regulatory element binding protein-1c activation in mediating skeletal muscle insulin resistance via repression of rat insulin receptor substrate-1 transcription